Psychedelics put to the test One of the most significant developments this summer was the results of the first double-blind, active placebo-controlled study to test psilocybin for alcohol

Summer is officially here, and psychedelic researchers are continuing their efforts to turn these medicines into viable therapy options. Despite relatively few clinical trials published

We’re now almost halfway through 2022, and psychedelic research shows no signs of slowing down. Over May, we continued to gain a better understanding of

Over April, we continued to learn more about psychedelic medicine. Researchers argued that psilocybin increases global integration in the depressed brain and that classic psychedelic

As the first quarter of 2022 came to a close we continue to discover more about psychedelics and their apparent therapeutic potential. March was another

Psychedelic research shows no sign of slowing down as researchers carried over the New Year’s momentum into February. Over the last month, we saw that